Have we made progress in the treatment of GVHD?

Best Practice and Research: Clinical Haematology

Volumn 25, Issue 4, 2012, Pages 473-478

  Harris, Andrew C ^a   Levine, John E ^a   Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

biomarker; gastrointestinal (GI); graft versus host disease (GVHD); hematopoietic cell transplantation (HCT); REG3

Indexed keywords

LECTIN; REGENERATING ISLET DERIVED 3 ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; CLINICAL PRACTICE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; SURVIVAL; VALIDATION STUDY;

ACUTE DISEASE; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; DISEASE-FREE SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTESTINAL DISEASES; LECTINS, C-TYPE; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 84870674539     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2012.10.010     Document Type: Review

References (21)

1. M.C. Pasquini, and Z. Wang Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides 2011
2. A. Mowat, and G. Socie Intestinal graft-vs-host disease J.L.M. Ferrara, K.R. Cooke, H.J. Deeg, Graft-vs-host disease 2004 Marcel Dekker New York 279 327
3. J.L. Ferrara, J.E. Levine, and P. Reddy Graft-versus-host disease Lancet 373 2009 1550 1561
4. P.J. Martin, G.B. McDonald, and J.E. Sanders Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 10 2004 320 327
5. M.L. MacMillan, D.J. Weisdorf, and J.E. Wagner Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems Biol Blood Marrow Transplant 8 2002 387 394
6. D. Przepiorka, D. Weisdorf, and P. Martin 1994 consensus conference on acute GVHD grading Bone Marrow Transplant 15 1995 825 828
7. H.M. Shulman, D. Kleiner, and S.J. Lee Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report Biol Blood Marrow Transplant 12 2006 31 47
8. M. Ertault-Daneshpouy, C. Leboeuf, and M. Lemann Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease Blood 103 2004 4681 4684
9. D. Weisdorf, R. Haake, and B. Blazar Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome Blood 75 1990 1024 1030
10. H.J. Deeg How I treat refractory acute GVHD Blood 109 2007 4119 4126
11. H.L. Cash, C.V. Whitham, and C.L. Behrendt Symbiotic bacteria direct expression of an intestinal bactericidal lectin Science 313 2006 1126 1130
12. M. Gironella, J.L. Iovanna, and M. Sans Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease Gut 54 2005 1244 1253
13. J.L. Ferrara, A.C. Harris, and J.K. Greenson Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease Blood 118 2011 6702 6708
14. V. Faca, S.J. Pitteri, and L. Newcomb Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes J Proteome Res 6 2007 3558 3565
15. S. Paczesny, T.M. Braun, and J.E. Levine Elafin is a biomarker of graft-versus-host disease of the skin Sci Transl Med 2 2010 13ra2
16. J.E. Levine, B. Logan, and J. Wu Graft-versus-host disease treatment: predictors of survival Biol Blood Marrow Transplant 16 2010 1693 1699
17. G.J. Cox, S.M. Matsui, and R.S. Lo Etiology and outcome of diarrhea after marrow transplantation: a prospective study Gastroenterology 107 1994 1398 1407
18. Y. Zheng, P.A. Valdez, and D.M. Danilenko Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens Nat Med 14 2008 282 289
19. S. Takashima, M. Kadowaki, and K. Aoyama The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells J Exp Med 208 2011 285 294
20. A. Gerbitz, M. Schultz, and A. Wilke Probiotic effects on experimental graft-versus-host disease: let them eat yogurt Blood 103 2004 4365 4367
21. D.A. Elphick, and Y.R. Mahida Paneth cells: their role in innate immunity and inflammatory disease Gut 54 2005 1802 1809